Results 101 to 110 of about 416,692 (196)

Estimating time-varying cholera transmission and oral cholera vaccine effectiveness in Haiti and Cameroon, 2021-2023. [PDF]

BMJ Open
Hulland EN, Charpignon ML, Hayek GY, Zhao L, Martoma R, Desai AN, Majumder MS.   +6 more
europepmc   +1 more source

Oral cholera vaccine coverage evaluation survey: Forcibly Displaced Myanmar Nationals and host community in Cox's Bazar, Bangladesh. [PDF]

Front Public Health, 2023
Qayum MO, Billah MM, Sarker MFR, Alamgir ASM, Nurunnahar M, Khan MH, Salim Uzzaman M, Henderson A, Shirin T, Flora MS.   +9 more
europepmc   +1 more source

Cost of oral cholera vaccine delivery in a mass immunization program for children in urban Bangladesh. [PDF]

Vaccine X, 2022
Sarker AR, Khan AI, Islam MT, Chowdhury F, Khanam F, Kang S, Ahmmed F, Im J, Kim DR, Tadesse BT, Ahmed T, Aziz AB, Hoque M, Park J, Liu X, Pak G, Zaman K, Marks F, Kim JH, Clemens JD, Qadri F.   +20 more
europepmc   +1 more source

Lessons learned from the deployment of oral cholera vaccine by maintaining the controlled temperature chain (CTC) in an urban setting, Bangladesh. [PDF]

Hum Vaccin Immunother
Islam MT, Khan AI, Khan ZH, Amin MA, Shahnaz S, Sultana QF, Bhuiyan MTR, Rimal A, Robertson J, Kahn AL, Qadri F.   +10 more
europepmc   +1 more source

Challenges for Programmatic Implementation of Oral Cholera Vaccine in India. [PDF]

J Infect Dis, 2021
Chakraborty D, Kanungo S, Kumar Nandy R, Kumar Deb A, Kumar Mukhopadhyay A, Dutta S.   +5 more
europepmc   +1 more source

Pre-vaccination biomarkers of enteric dysfunction, inflammation and nutritional status associate with seroconversion to oral cholera vaccine and are perturbed during natural infection. [PDF]

Front Immunol
Liswaniso F, Phiri B, Chibuye M, Luchen CC, Ngosa D, Ng'ombe H, Chibesa K, Muchimba M, Chilengi R, Bosomprah S, Chisenga CC.   +10 more
europepmc   +1 more source

Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia. [PDF]

BMC Public Health, 2023
Chisenga CC, Bosomprah S, Chilyabanyama ON, Alabi P, Simuyandi M, Mwaba J, Ng'ombe H, Laban NM, Luchen CC, Chilengi R.   +9 more
europepmc   +1 more source

An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon. [PDF]

Am J Trop Med Hyg, 2022
Ateudjieu J, Sack DA, Nafack SS, Xiao S, Tchio-Nighie KH, Tchokomeni H, Bita'a LB, Nyibio PN, Guenou E, Mondung KM, Dieumo FFK, Ngome RM, Murt KN, Ram M, Ali M, Debes AK.   +15 more
europepmc   +1 more source

Strategies for achieving a healthy oral cholera vaccine market: Model-enabled scenario exploration of supply and demand dynamics. [PDF]

PLoS Negl Trop Dis
Guttieres D, Van Riet C, Vandaele N, Decouttere C.   +3 more
europepmc   +1 more source

Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine. [PDF]

Am J Trop Med Hyg, 2022
Duffin RP, Delbuono M, Nishioka K, Shabram P, Patel AA.   +4 more
europepmc   +1 more source